Search For "serum"
Leading India biopharma standardizes on Veeva Vault PromoMats to speed sci
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India], March 25 (ANI/BusinessWire India): Veeva Systems (NYSE: VEEV) today announced one of India's fastest-growing biopharma companies, Bharat Serums and Vaccines Limited (BSV), is standardizing on Veeva Vault PromoMats to accelerate its end-to-end content lifecycle f
Read More
DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years.
Read More
SEC recommends granting emergency use authorisation to Serum Institute of
Updated : 4 years ago IST
New Delhi [India], March 4 (ANI): The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine Covovax for the age group 12-17, said the official sources.
Read More
US FDA grants the coveted Breakthrough Designation for early-stage prostat
Updated : 4 years ago IST
Mumbai (Maharashtra) [India], February 15 (ANI/PR Newswire): Datar Cancer Genetics today announced that the US Food and Drug Administration (FDA) has granted 'Breakthrough Designation' for its blood test to detect early-stage prostate cancer. This is the second test from the Company that has
Read More
SII provided COVID-19 vaccine at 'cost of cup of tea', saved nearly two-th
Updated : 4 years ago IST
Pune (Maharashtra) [India], February 14 (ANI): Padma Bhushan-awardee and industrialist Cyrus Poonawala on Monday said Serum Institute of India (SI) provided COVID-19 vaccine at "the cost of a cup of tea" and saved nearly two-thirds infant population in the world.
Read More
Study of genetics discovers new acne risk genes, provides hope for new tre
Updated : 4 years, 1 month ago IST
London [England], February 7 (ANI): The thing that everyone hates but can't get rid of overnight, is undoubtedly, acne. People spend money on every possible facewash, serum or scrub that can help them get rid of it. Now, a recent study of the genetics of acne has identified 29 regions of the
Read More
Trycone adds three new skin care serums to its product line
Updated : 4 years, 1 month ago IST
New Delhi [India], February 7 (ANI/SRV): Trycone, one of India's leading beauty and personal care brands, has added three new serums to its range of high-quality skincare products.
Read More
Researchers accelerate cancer biomarker detection for point of care diagno
Updated : 4 years, 1 month ago IST
Washington [US], January 31 (ANI): A team of researchers has developed an approach that accelerates the detection of cancer biomarkers in samples taken at the time and place of patient care.
Read More
Thank govt for acknowledging my mentor, my hero: Adar Poonawalla on his fa
Updated : 4 years, 1 month ago IST
New Delhi [India], January 25 (ANI): Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year.
Read More
SII Chairman and MD Cyrus Poonawalla to be conferred with Padma Bhushan
Updated : 4 years, 1 month ago IST
New Delhi [India], January 25 (ANI): Serum Institute of India (SII) Chairman and Managing Director Cyrus Poonawalla will be conferred with Padma Bhushan, announced the Centre on Tuesday, on the eve of the 73rd Republic Day.
Read More
SEC recommends regular market approval to Covaxin, Covishield for adults
Updated : 4 years, 1 month ago IST
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po
Read More
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 1 month ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More